---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-122110"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T11:10:13.385895+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ResMed Q3 FY2023 revenue +29% to $1.12B; EPS $1.58, non-GAAP $1.68

## Summary
- Revenue $1,116.9M, up 29% YoY (31% constant currency); diluted EPS $1.58, non-GAAP $1.68.
- Operating income +28% to $300.7M; non-GAAP operating income +27% to $321.2M.
- Gross margin contracted 150 bps to 55.3%; non-GAAP gross margin down 200 bps to 56.1%.
- CEO: full global availability of AirSense 10; ramping AirSense 11; strong mask and SaaS growth.
- Quarterly dividend $0.44/share declared; payable June 15, record May 11.

## SEC filing metadata
- accession: 0001193125-23-122110
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312523122110/0001193125-23-122110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312523122110/d477335d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-122110
- JSON: https://secwatch.observer/filing/0001193125-23-122110.json
- Plain text: https://secwatch.observer/filing/0001193125-23-122110.txt

## Key facts
- Earnings Releases
  RESMED INC reported the quarter ended March 31, 2023 results: revenue $1,116.9 million, EPS $1.58.
  - Period: the quarter ended March 31, 2023
  - Revenue: $1,116.9 million
  - EPS: $1.58
  - Result: reported results
  source text: ASX: RMD) today announced results for its quarter ended March 31, 2023. Third Quarter 2023 Highlights All comparisons are to the prior year period • Revenue increased by 29% to $1,116.9 million; up 31% on a constant currency basis • Gross margin contracted 150 bps to 55.3%; non-GAAP gross margin contracted 200 bps to 56.1% • Income from operations increased 28%;
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312523122110/0001193125-23-122110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.